latest
Market/Novel Tech Articles

Alkahest’s oral small molecule drug aims to report on a Phase IIa study for age-related macular degeneration

Alkahest Inc., a clinical stage biopharmaceutical company based in San Carlos, California, has announced that an experimental drug, AKST4290, in a Phase IIa study for AMD, showed that  83% of patients maintained or improved their visual acuity, and 21% of patients gained at least 15 letters in BCVA. The open-label Hungarian trial enrolled 29 patients […]

Read full story

Gyroscope Therapeutics and Orbit Biomedical have merged into a new retinal gene therapy company

The following two biomedical companies – Gyroscope Therapeutics in Stevenage UK and Orbit Biomedical in Philadelphia, US – have announced that they have merged in a combined entity to build “precise and targeted delivery of gene and cell therapies into the retina”. The company will maintain the Gyroscope name, and the press release has stated […]

Read full story

Drug companies sued in multiple States over price-fixing of generic drugs, several leading up to 1,000% increase of cost to patients

Global news reports have highlighted a lawsuit in 44 states in the US for price-fixing and collusion among several large pharmaceutical companies.  Following for the shares fell for Teva, Mylan, Novartis, Sandoz, Pfizer and others.  Over 100 pharmaceutical products linked to the lawsuit includes drugs such as lamivudine-zidovudine for H.I.V. treatment; budesonide for asthma; fenofibrate […]

Read full story

Related Market/Novel Tech News